Loading Events

Event

May 2021 25
Time: 8:00 AM

Tuesday, May 18 from 7AM-10:30AM EST | Friday, May 21 from 8AM-11:30AM EST | Tuesday, May 25 from 8AM-11:30AM EST

The global response to COVID-19 has pushed the boundaries on what is possible for rapid pandemic response in several areas, including advancing vaccine research and development, bolstering vaccine distribution and supply chains, reinforcing non-vaccine public health interventions and countermeasures, and encouraging global coordination, partnerships and financing. Furthermore, the global COVID-19 response has provided new data around the efficacy and best practices surrounding pandemic planning and response.

This global public workshop will convene international experts, thought-leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.


Agenda:

Panel 1: Creating Conditions for Innovation in Research and Development

  • Beverly Taylor, Moderator | Head, Influenza Scientific Affairs, Seqirus Vaccines; Chair, Influenza Vaccine Supply Task Force, IFPMA
  • Charu Kaushic | Chair, Global Research Collaboration for Infectious Disease Preparedness; Scientific Director, Canadian Institutes of Health Research
  • Maria Elena Bottazzi | Associate Dean, National School of Tropical Medicine, Baylor College of Medicine
  • Carolyn Finkle | Chief Operating Officer, Medicago


Panel 2: Communicating the Science of Viruses and Vaccines

  • Heidi Larson, Moderator | Founding Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
  • Benjamin Cowling | Head, Division of Epidemiology and Biostatistics, Hong Kong University
  • Priya Bahri | Principal Scientific Officer, European Medicines Agency
  • Sherine Guirguis | Director, Common Thread
  • Sarah Zhang | Staff Writer, The Atlantic

 

Breakout sessions

Breakout 1: Information Sharing and Communications

  • Heidi Larson, Moderator | Founding Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
  • Denise Gray-Felder | President and CEO, CFSC Consortium
  • Priya Bahri | Principal Scientific Officer, European Medicines Agency
  • Glen Nowak | Director of Center for Health & Risk Communication, University of Georgia
  • Sergio Cecchini | Coordinator, Africa Infodemic Response Alliance

Breakout 2: Financing and Investment

  • Phyllis Arthur, Moderator | Vice President, Infectious Diseases & Diagnostics Policy at Biotechnology Innovation Organization
  • Ran Balicer | Chief Innovation Officer, Clalit Health Services
  • Maria Elena Bottazzi | Associate Dean, National School of Tropical Medicine, Baylor College of Medicine

Breakout 3: Equity in Research and Communication

  • Patricia Garcia, Moderator | Professor, Universidad Peruana Cayetano Heredia
  • Sherine Guirguis | Director, Common Thread
  • Tolbert Nyenswah | Senior Research Associate, Johns Hopkins University

The workshop will feature invited presentations and discussions to:

  • Highlight late-breaking developments in vaccine R&D or manufacturing that can inform future pandemic influenza planning.
  • Explore current global coordination frameworks and opportunities for future pandemic planning, including funding mobilization, technology transfer, and surveillance and data sharing.
  • Discuss lessons learned from COVID-19 vaccine rollout and delivery, as well as public health countermeasures sourcing, including inventory unpredictability and cascading effects of shortages of critical inputs and ancillary materials.
  • Explore gaps in One Health governance, global surveillance, and risk assessment.
  • Highlight equity challenges in the “last mile” of medical product delivery, and needs identified in order to improve future planning and deployment of products.
  • Explore innovations in surveillance and data sharing during COVID-19 and other epidemics that can be adapted and scaled for future influenza events.
  • Discuss best practices for communicating emerging research and building public confidence in vaccines and public health measures.

The deliberations of this workshop will also inform the four study committees related to this project: (1) Vaccine research and development, including platforms in discovery and manufacturing, (2) Vaccine distribution and supply chain, (3) Non-vaccine public health interventions and countermeasures, and (4) International coordination, innovative partnerships, and sustainable financing for influenza preparedness and response.


Day 1 of the Workshop

Day 2 of the Workshop

Initiative Homepage

Join Our Community

Sign up for NAM email updates